BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

471 related articles for article (PubMed ID: 30190364)

  • 1. Quantitative assessment of outer retinal layers and ellipsoid zone mapping in hydroxychloroquine retinopathy.
    Ugwuegbu O; Uchida A; Singh RP; Beven L; Hu M; Kaiser S; Srivastava SK; Ehlers JP
    Br J Ophthalmol; 2019 Jan; 103(1):3-7. PubMed ID: 30190364
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Assessment of inner and outer retinal layer metrics on the Cirrus HD-OCT Platform in normal eyes.
    Arepalli S; Srivastava SK; Hu M; Kaiser PM; Dukles N; Reese JL; Ehlers JP
    PLoS One; 2018; 13(10):e0203324. PubMed ID: 30286099
    [TBL] [Abstract][Full Text] [Related]  

  • 3. VOLUMETRIC SINGLE-LAYER INNER RETINAL ANALYSIS IN PATIENTS WITH HYDROXYCHLOROQUINE TOXICITY.
    Modi YS; Au A; Parikh VS; Ehlers JP; Schachat AP; Singh RP
    Retina; 2016 Oct; 36(10):1941-50. PubMed ID: 27258672
    [TBL] [Abstract][Full Text] [Related]  

  • 4. LONGITUDINAL CHANGES IN EYES WITH HYDROXYCHLOROQUINE RETINAL TOXICITY.
    Allahdina AM; Chen KG; Alvarez JA; Wong WT; Chew EY; Cukras CA
    Retina; 2019 Mar; 39(3):473-484. PubMed ID: 30741731
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Localization of damage in progressive hydroxychloroquine retinopathy on and off the drug: inner versus outer retina, parafovea versus peripheral fovea.
    de Sisternes L; Hu J; Rubin DL; Marmor MF
    Invest Ophthalmol Vis Sci; 2015 May; 56(5):3415-26. PubMed ID: 26024126
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Machine Learning-Based Automated Detection of Hydroxychloroquine Toxicity and Prediction of Future Toxicity Using Higher-Order OCT Biomarkers.
    Kalra G; Talcott KE; Kaiser S; Ugwuegbu O; Hu M; Srivastava SK; Ehlers JP
    Ophthalmol Retina; 2022 Dec; 6(12):1241-1252. PubMed ID: 35691579
    [TBL] [Abstract][Full Text] [Related]  

  • 7. En Face Optical Coherence Tomography Imaging of the Photoreceptor Layers in Hydroxychloroquine Retinopathy.
    Ahn SJ; Joung J; Lee BR
    Am J Ophthalmol; 2019 Mar; 199():71-81. PubMed ID: 30448463
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Visual Field Sensitivity Prediction Using Optical Coherence Tomography Analysis in Hydroxychloroquine Toxicity.
    Jayakar G; De Silva T; Cukras CA
    Invest Ophthalmol Vis Sci; 2022 Jan; 63(1):15. PubMed ID: 35015028
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Macular ganglion cell-inner plexiform layer thickness for detection of early retinal toxicity of hydroxychloroquine.
    Kan E; Yakar K; Demirag MD; Gok M
    Int Ophthalmol; 2018 Aug; 38(4):1635-1640. PubMed ID: 28695378
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Imaging of Hydroxychloroquine Toxicity with Fluorescence Lifetime Imaging Ophthalmoscopy.
    Sauer L; Calvo CM; Vitale AS; Henrie N; Milliken CM; Bernstein PS
    Ophthalmol Retina; 2019 Oct; 3(10):814-825. PubMed ID: 31345727
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evolution of retinal changes measured by optical coherence tomography in the assessment of hydroxychloroquine ocular safety in patients with systemic lupus erythematosus.
    Martín-Iglesias D; Artaraz J; Fonollosa A; Ugarte A; Arteagabeitia A; Ruiz-Irastorza G
    Lupus; 2019 Apr; 28(4):555-559. PubMed ID: 30755141
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of Retromode Imaging for Use in Hydroxychloroquine Retinopathy.
    Ahn SJ; Lee SU; Lee SH; Lee BR
    Am J Ophthalmol; 2018 Dec; 196():44-52. PubMed ID: 30118686
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of Structural Changes on Multifocal Electroretinography in Patients With Use of Hydroxychloroquine.
    Borrelli E; Battista M; Cascavilla ML; Viganò C; Borghesan F; Nicolini N; Clemente L; Sacconi R; Barresi C; Marchese A; Miserocchi E; Modorati G; Bandello F; Querques G
    Invest Ophthalmol Vis Sci; 2021 Sep; 62(12):28. PubMed ID: 34581725
    [TBL] [Abstract][Full Text] [Related]  

  • 14. SEQUENTIAL CHANGES IN HYDROXYCHLOROQUINE RETINOPATHY UP TO 20 YEARS AFTER STOPPING THE DRUG: Implications for Mild Versus Severe Toxicity.
    Pham BH; Marmor MF
    Retina; 2019 Mar; 39(3):492-501. PubMed ID: 30550532
    [TBL] [Abstract][Full Text] [Related]  

  • 15. TOXIC EFFECTS OF HYDROXYCHLOROQUINE ON THE CHOROID: Evidence From Multimodal Imaging.
    Ahn SJ; Ryu SJ; Lim HW; Lee BR
    Retina; 2019 May; 39(5):1016-1026. PubMed ID: 29373341
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Early hydroxychloroquine retinopathy: optical coherence tomography abnormalities preceding Humphrey visual field defects.
    Garrity ST; Jung JY; Zambrowski O; Pichi F; Su D; Arya M; Waheed NK; Duker JS; Chetrit Y; Miserocchi E; Giuffrè C; Kaden TR; Querques G; Souied EH; Freund KB; Sarraf D
    Br J Ophthalmol; 2019 Nov; 103(11):1600-1604. PubMed ID: 30819690
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Early retinal and retinal nerve fiber layer effects of hydroxychloroquine: a follow up study by sdOCT.
    Yülek F; Uğurlu N; Akçay E; Kocamış Sİ; Gerçeker S; Erten Ş; Midillioğlu İ; Şimşek Ş
    Cutan Ocul Toxicol; 2013 Sep; 32(3):204-9. PubMed ID: 23351071
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Volumetric ellipsoid zone mapping for enhanced visualisation of outer retinal integrity with optical coherence tomography.
    Itoh Y; Vasanji A; Ehlers JP
    Br J Ophthalmol; 2016 Mar; 100(3):295-9. PubMed ID: 26201354
    [TBL] [Abstract][Full Text] [Related]  

  • 19. OCT Angiography and Ellipsoid Zone Mapping of Macular Telangiectasia Type 2 From the AVATAR Study.
    Runkle AP; Kaiser PK; Srivastava SK; Schachat AP; Reese JL; Ehlers JP
    Invest Ophthalmol Vis Sci; 2017 Jul; 58(9):3683-3689. PubMed ID: 28727884
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fluorescence Lifetimes in Patients With Hydroxychloroquine Retinopathy.
    Solberg Y; Dysli C; Möller B; Wolf S; Zinkernagel MS
    Invest Ophthalmol Vis Sci; 2019 May; 60(6):2165-2172. PubMed ID: 31108547
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.